Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Anticancer Research|July 29, 2026
Analysis for IL-22/ IL-22BP Axis and Cell Adhesion Molecules in Advanced Colorectal CancerNaohiro Yoshida, Masayuki Takamatsu, Kenta Takaki, et al.
International Journal of Clinical Oncology|March 17, 2026
A paradigm shift in genetic predisposition to colorectal cancer: the impact of germline multigene panel testing on diagnosis and managementKenji Fujiyoshi, Tomoya Sudo, Satoshi Shimamura, et al.
The Kurume Medical Journal|March 24, 2017
Evaluation of Surgical Procedures for T2 Gallbladder Cancer in Terms of Recurrence and PrognosisRyuichi Kawahara, Takahisa Shirahama, Shyoichirou Arai, et al.
Anticancer Research|July 27, 2022
Salvage PTBD With Chemotherapy Improves Survival in Patients With Unresectable Malignant Biliary Obstruction - A Single Center Retrospective StudyDaisuke Muroya, Hirotoshi Tsuru, Hisaaki Shimokobe, et al.
Anticancer Research|August 2, 2019
Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver MetastasisToru Hisaka, Hiroto Ishikawa, Hisamune Sakai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Endoscopic retrograde biliary drainage for the liver metastases from colorectal cancer and obstructive jaundice]Yuhei Kitasato, Yusuke Ishida, Yoshinobu Okabe, et al.
The Kurume Medical Journal|April 2, 2023
Prognostic Factors for Distal Bile Duct Carcinoma After SurgeryRyuichi Kawahara, Ryuuta Midorikawa, Shinichi Taniwaki, et al.
Cancer Medicine|June 11, 2026
Comparison of Interferon-Based and Interferon-Free Treatments on the Prognosis of Hepatocellular Carcinoma After Hepatitis C Virus-Sustained Virological Response: A Multicenter StudyShinji Itoh, Norifumi Iseda, Tomoharu Yoshizumi, et al.
The Kurume Medical Journal|July 30, 2023
Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical TrialYuichi Goto, Takashi Niizeki, Shogo Fukutomi, et al.
Pageof 7